Keith Couper
@KeithCouper
Followers
1K
Following
3K
Statuses
2K
Clinical academic nurse- Warwick Uni (Associate Prof) and University Hospitals Birmingham NHS Foundation Trust (Critical care outreach). Views are my own.
Birmingham
Joined November 2012
RT @InflamAge_UoB: Huge congratulations to @drdhruvparekh on his appointment as Medical Director of Research, Development & Innovation (RDI…
0
17
0
RT @EPPiC_Warwick: PROTECT Airways has registered to the NIHR API Scheme. Follow the link to find out more or register your interest https:…
0
9
0
RT @LeechCaroline: ⭐ Just published! ⭐ Maternal and neonatal outcomes following resuscitative hysterotomy for out of hospital cardiac arr…
0
109
0
RT @AsgerGranfeldt: Thank you @KeithCouper for leading the way on this important meta-analysis Intraosseous and intravenous vascular acces…
0
5
0
RT @EmergencyMedBMJ: 📝 BMJ Group is seeking an ambitious and visionary Editor-in-Chief to lead EMJ from January 2026. Find out how to apply…
0
8
0
RT @EPPiC_Warwick: Congratulations to Gavin Perkins ( @perkins_gd) on being awarded an MBE for services to Resuscitation science. @Warwick…
0
12
0
RT @LukeFlower1: 🧵1/6 The final @TRICNetwork NEAT-ECHO paper has been published in @yourICM ! A summary: 🏥 179 ICUs 📡 96% of teams had a…
0
23
0
RT @AdamBoulton17: Second paper from NEAT-ECHO is out @TRICNetwork @yourICM 🎉 Big thank you to all collaborators across the UK who made th…
0
3
0
Fantastic work led by @darknatter and delivered by the phenomenal UK Critical Care community. We can safely reduce antibiotic duration using procalcitonin (but not CRP). @AdaptSepsis @WarwickCTU
Published in JAMA with #CCRdownunder: In critically ill adults with suspected sepsis, antibiotic regimens were safely reduced when guided by measurement of procalcitonin but not by C-reactive protein. @CritCareReviews
0
6
17
@RaiedOtaibi @atula_tweets Congratulations- thank you for letting me be a part of the last stage of your PhD journey.
0
0
2
RT @KeithCouper: PARAMEDIC-3 Trial results webinar Are you a UK ambulance service clinician (or just interested in PARAMEDIC-3)? We have…
0
31
0
RT @_Maljanoubi: I am incredibly thrilled to be part of the ILCOR's latest Consensus on Science with Treatment Recommendations and to be re…
0
7
0
PARAMEDIC-3 Trial results webinar Are you a UK ambulance service clinician (or just interested in PARAMEDIC-3)? We have places left at our webinar next Tuesday. Come and hear the trial results, then ask our expert panel questions. Register here:
2
31
50
RT @CritCareReviews: ➡️The PARAMEDIC3 & IVIO trials were presented at #ERC24 & published in @NEJM 2 weeks ago ➡️We have a podcast on eac…
0
3
0
RT @CritCareReviews: ➡️The PARAMEDIC3 & IVIO trials were presented at #ERC24 & published in @NEJM 2 weeks ago. ➡️IO vs IV vascular access…
0
9
0
RT @gregwhitley7: I am delighted to share some news... I have been promoted to Associate Professor in Paramedic Science at the University o…
0
7
0
@Interestbroadly PARAMEDIC-3 has not looked at this yet... It's on our list (coming soon). But... The Danish IVIO trial randomised between IV and IO (then sub-randomised IO to humeral or tibial). No clear benefit to either route... Maybe slightly in favour of tibial.
0
0
1
@Rob_Smithers @ERC_resus @NEJM The decision to randomise was made by the clinician at scene... If there was an absolute indication for a specific route then they could obviously choose not to randomise. Key ethical considerations are outlined in the protocol which is available with the published paper.
0
0
2
RT @wmcareteam: This month's CARE Team Sessions- 𝗟𝗲𝗰𝘁𝘂𝗿𝗲 - 𝗕𝗮𝗿𝗿𝗶𝗲𝗿𝘀 𝘁𝗼 𝗯𝘆𝘀𝘁𝗮𝗻𝗱𝗲𝗿 𝗖𝗣𝗥 𝗟𝗲𝗰𝘁𝘂𝗿𝗲 - 𝗣𝗔𝗥𝗔𝗠𝗘𝗗𝗜𝗖-𝟯 𝘁𝗿𝗶𝗮𝗹 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽𝘀 - 𝗔𝗶𝗿…
0
4
0